Home Cart 0 Sign in  
X

[ CAS No. 22246-16-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 22246-16-8
Chemical Structure| 22246-16-8
Chemical Structure| 22246-16-8
Structure of 22246-16-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 22246-16-8 ]

Related Doc. of [ 22246-16-8 ]

Alternatived Products of [ 22246-16-8 ]

Product Details of [ 22246-16-8 ]

CAS No. :22246-16-8 MDL No. :MFCD00559317
Formula : C9H8N2O3 Boiling Point : -
Linear Structure Formula :- InChI Key :NQMSVHWAVMTBHK-UHFFFAOYSA-N
M.W : 192.17 Pubchem ID :5111749
Synonyms :

Calculated chemistry of [ 22246-16-8 ]

Physicochemical Properties

Num. heavy atoms : 14
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.22
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 55.36
TPSA : 74.92 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.64 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.25
Log Po/w (XLOGP3) : 1.17
Log Po/w (WLOGP) : 0.91
Log Po/w (MLOGP) : 0.36
Log Po/w (SILICOS-IT) : -0.13
Consensus Log Po/w : 0.71

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.02
Solubility : 1.84 mg/ml ; 0.00956 mol/l
Class : Soluble
Log S (Ali) : -2.34
Solubility : 0.881 mg/ml ; 0.00459 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.55
Solubility : 0.539 mg/ml ; 0.00281 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.8

Safety of [ 22246-16-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 22246-16-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 22246-16-8 ]
  • Downstream synthetic route of [ 22246-16-8 ]

[ 22246-16-8 ] Synthesis Path-Upstream   1~8

  • 1
  • [ 22246-16-8 ]
  • [ 22246-13-5 ]
YieldReaction ConditionsOperation in experiment
91% With ammonium chloride; zinc In methanol at 0 - 20℃; for 1 h; To a solution of 6-nitro-3,4-dihydroquinolin-2(lH)-one (3 g) in MeOH (60 mL) at 0°C, Zn dust (5 eq) and ammonium chloride (5 eq) were added portion wise and the mixture stirred at rt for 1 h while monitoring by TLC. After completion, the mixture was filtered over Celite® bed and resulting filtrate concentrated. The residue was diluted with 5percent MeOH in DCM and washed with water. The organic layer was dried over sodium sulfate, filtered and concentrated to obtain 6-amino-3,4-dihydroquinolin-2(lH)-one (2.3 g, 91percent). 1H NMR (DMSO-d6, 400 MHz): δ 9.654 (brs, 1H), 6.53 (d, 1H), 6.378-6.334 (m, 2H), 4.707 (brs, 2H), 2.699 (t, 2H), 2.330 (t, 2H).
63% With hydrogen In methanol To a suspension of l,2-dihydro-6-nitroisoquinolin-3(4H)-one (10.3 g, 53.6 mmol) in MeOH (150 mL) was added 10percent Pd/C (1.14 g, 1.07 mmol) and the mixture was stirred overnight under H2 (1 atm). After filtration, the filtrate was concentrated and the residue was suspended in acetone, filtered and precipitated with cone. HCl (10 mL). The resulting precipitate was collected, washed with H2O and acetone and recrystallized from MeOH/H2O to yield 6-amino-l,2-dihydroisoquinolin-3(4H)-one as a grey solid (6.7 g, 63 percent yield).
1.8 g With ammonium chloride; zinc In ethanol; water at 80℃; for 1 h; 6-Nitro-3,4- dihydroquinolin-2(lH)-one (1.0 g, 5.2 mmol) was dissolved in 40 mL of EtOH, and then H4CI (2.76 g, 52 mmol) in 20 mL of H2O and Zn dust (2.37 g, 36.4 mmol) were added. After refluxing at 80 °C for 1 h, the mixture was filtered to remove Zn dust. The filtration was concentrated to give the desired product (1.8 g, including partial H4CI) as a gray solid. NMR (300 MHz, DMSO-^e) δ 9.67 (s, 1H), 6.55 (d, J = 8.2 Hz, 1H), 6.42 - 6.31 (m, 2H), 2.70 (t, J= 7.5 Hz, 2H), 2.33 (dd, J= 8.5 Hz, 6.5 Hz, 2H).
Reference: [1] Patent: WO2015/38417, 2015, A1, . Location in patent: Page/Page column 90; 91
[2] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 16, p. 4606 - 4609
[3] Patent: WO2006/71940, 2006, A2, . Location in patent: Page/Page column 416
[4] Proceedings of the Imperial Academy (Tokyo), 1939, vol. 15, p. 148,153[5] Chem. Zentralbl., 1939, vol. 110, # II, p. 3089
[6] Archiv der Pharmazie, 2008, vol. 341, # 12, p. 794 - 799
[7] European Journal of Medicinal Chemistry, 2014, vol. 73, p. 217 - 224
[8] Patent: WO2016/33100, 2016, A1, . Location in patent: Page/Page column 145
[9] European Journal of Medicinal Chemistry, 2018, vol. 151, p. 450 - 461
[10] Patent: WO2018/112037, 2018, A1, . Location in patent: Paragraph 0146
  • 2
  • [ 22246-16-8 ]
  • [ 29969-57-1 ]
YieldReaction ConditionsOperation in experiment
95%
Stage #1: With 2,3-dicyano-5,6-dichloro-p-benzoquinone; trichlorophosphate In benzene at 90℃; for 3 h;
Stage #2: With sodium hydroxide In water; benzene
Step 4 2-Chloro-6-nitroquinoline: To a solution of 6-nitro-3,4-dihydroquinolin-2(1H)-one (8.2 g, 41.9 mmol) in benzene (150 mL) was added DDQ (9.6 g, 42.5 mmol) followed by dropwise addition of POCl3 (20.5 mL). The resulting solution was heated at 90° C. for 3 h. The reaction mixture was cooled to room temperature then quenched by adding 500 mL of H2O/ice. The pH was adjusted to 7 by the addition of 4N NaOH. The resulting solution was extracted from EtOAc (3.x.1 L). The combined organic layers were concentrated under reduced pressure to yield the desired product, 8.4 g (95percent), as a yellow solid.
Reference: [1] Heterocycles, 1998, vol. 48, # 12, p. 2637 - 2641
[2] Patent: US2007/27184, 2007, A1, . Location in patent: Page/Page column 18; 25
[3] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 20, p. 5270 - 5274
[4] Patent: KR101576386, 2015, B1, . Location in patent: Paragraph 0190; 0193-0194
  • 3
  • [ 553-03-7 ]
  • [ 22246-16-8 ]
YieldReaction ConditionsOperation in experiment
90% With sulfuric acid; nitric acid In water at 0℃; for 0.25 h; Step 3 6-Nitro-3,4-dihydroquinolin-2(1H)-one: To a solution of 3,4-dihydroquinolin-2(1H)-one (7.2 g, 46.5 mmol) in H2SO4 (150 mL) at 0° C. was added water (35 ml) dropwise with stirring. To the reaction solution was added HNO3 (3.5 mL) dropwise with stirring, while cooling to a temperature of 0° C. The resulting solution was stirred for 15 min at 0° C. The reaction mixture was then quenched by adding 350 mL of H2O/ice. The resulting solution was extracted from EtOAc (5.x.250 mL). The combined organic layers were concentrated under reduced pressure to afford the desired product, 8.2 g (90percent), as a yellow solid.
88% With sulfuric acid; nitric acid In water at -10℃; for 0.166667 h; To a solution of hydrocarbostyril (9.00 g, 61.2 mmol) in cone. H2SO4 (180 mL) cooled to -10 °C was slowly added H2O (45 mL), followed by HNO3 (65percent, 4.5 mL). The yellow solution was stirred at -10 °C for 10 min and then carefully quenched at -10 °C with H2O (500 mL). The precipitated yellow solid was filtered off, washed with H2O and dried in vacuo to yield l,2-dihydro-6-nitroisoquinolin-3(4H)-one (10.3 g, 88percent yield).
82% With sulfuric acid; nitric acid In water at -10 - 0℃; for 0.416667 h; Example 3
6-nitro-3,4-dihydroquinolin-2(1H)-one
To a 250 mL round bottom flask continat 3,4-dihydro-2-(1H)-quinoline (3.00 g, 20.38 mmol) and a magnetic stirbar was added concentrated sulphuric acid (60 mL).
The argon purged reaction was placed into an ice-methanol bath (~-10° C.) and stirred to dissolve the solid.
Distilled water (15 mL) was added.
A 45percent solution of fuming nitric acid in water (2.86 mL, 20.43 mmol) was added dropwise to the colorless reaction.
The orange-red solution was stirred at -10-0° C. for 25 minutes.
The reaction was quenched by poured onto an ice-water slush (300 mL).
The ice was allowed to melt, and the pale yellow solid collected by vacuum filtration.
The solid was washed with water (3.50 mL).
After drying under suction, the product was washed again with ether (3*30 mL). TLC (1:1 EtOAc:Hexanes) revealed presence of some starting material.
The product was washed on the filter with dichloromethane (2*30 mL). TLC revealed the solid was pure desired product, and the filtrate wash contained both starting material and product. Yield: 3.20 g of yellow solid (82percent).
1H NMR (DMSO) δ: 10.68 (br s, 1H), 8.11 (s, 1H), 8.07 (d, J=8.7 Hz, 1H), 7.00 (d, J=8.7 Hz, 1H), 3.01 (t, J=7.2 Hz, 2H), 2.53 (t, J=7.8 Hz, 2H).
76% With sulfuric acid; nitric acid In water at -10℃; for 1.08333 h; 3,4-Dihydro-2 (lH)-quinolinone (1.0 g, 6.70 mmol) is dissolved in 20 mL of concentrated sulfuric acid at-10°C, and then 5 mL of water is added slowly to the solution. After 5 minutes, 61percent nitric acid (0.5 mL, 6.70 mmol) is added dropwise to the solution. The reaction mixture turns from yellow to dark red, and eventually solidifies. After 1 hour, water (50 mL) is added slowly at-10°C and precipitate appears. The solution is poured into a separatory funnel, extracted with ethyl acetate (20 mL x 2) and washed with saline (20 mL). The organic layers are collected and dried over MgS04. Solvent is removed and the title compound is obtained as a pale yellow solid (1.0 g, 76percent) ; 1H NMR (300 MHz, DMSO) 8 10.66 (s, 1H), 8.08-8. 01 (m, 2H), 6.96 (d, 1H), 2.98 (t, 2H), 2.49 (dd, 2H).
76% With sulfuric acid; nitric acid In water at -10℃; for 1.08333 h; Step 1:
Preparation of 6-nitro-3,4-dihydro-1H-quinolin-2-one
3,4-Dihydro-2(1H)-quinolinone (1.0 g, 6.70 mmol) is dissolved in 20 ML of concentrated sulfuric acid at -10° C., and then 5 ML of water is added slowly to the solution.After 5 minutes, 61percent nitric acid (0.5 ML, 6.70 mmol) is added dropwise to the solution.The reaction mixture turns from yellow to dark red, and eventually solidifies.After 1 hour, water (50 ML) is added slowly at -10° C. and precipitate appears.The solution is poured into a separatory funnel, extracted with ethyl acetate (20 ML*2) and washed with saline (20 ML).The organic layers are collected and dried over MgSO4.Solvent is removed and the title compound is obtained as a pale yellow solid (1.0 g, 76percent); 1H NMR (300 MHz, DMSO) δ 10.66 (s, 1H), 8.08-8.01 (m, 2H), 6.96 (d, 1H), 2.98 (t, 2H), 2.49 (dd, 2H).
76% at -20 - 20℃; for 4.5 h; 3,4-Dihydroquinolin-2(1H)-one (20.0 g, 136.05 mmol) was added to conc. sulfuric acid (200 ml) and cooled to −20° C., and fuming nitric acid (4 ml, 95.24 mmol) was then added carefully over a period of 30 minutes. The resulting reaction mixture was stirred at −20° C. for 2 h and at room temperature for a further 2 h and then slowly diluted with ice-water. The aqueous phase was then repeatedly extracted with ethyl acetate. The combined organic phases were dried over magnesium sulfate, filtered and concentrated under reduced pressure. By column chromatography purification of the crude product obtained (ethyl acetate/heptane gradient), 6-nitro-3,4-dihydroquinolin-2(1H)-one (20.0 g, 76percent of theory) was isolated as a colorless solid. 6-Nitro-3,4-dihydroquinolin-2(1H)-one (8.52 g, 44.38 mmol) was dissolved under argon in abs. N,N-dimethylformamide (150 ml), the mixture was cooled to 0° C. and fine potassium carbonate powder (7.40 g, 52.26 mmol) was added. After 15 min of stirring at a temperature of 0° C., n-propyl iodide (2 equiv, 88.771 mmol) was added. The resulting reaction mixture was stirred at room temperature for 24 h and, after cooling to room temperature, water and ethyl acetate were added. The aqueous phase was then repeatedly extracted with ethyl acetate. The combined organic phases were dried over magnesium sulfate, filtered and concentrated under reduced pressure. Column chromatography purification of the crude product obtained (ethyl acetate/heptane gradient), gave 6-nitro-1-propyl-3,4-dihydroquinolin-2(1H)-one (8.40 g, 87percent of theory) as a colorless solid. In the next step, 6-nitro-1-propyl-3,4-dihydroquinolin-2(1H)-one (5.0 g, 24.27 mmol) was dissolved in an ethanol/water mixture (ratio 1:1, 50 ml), and ammonium chloride (12.96 g, 242.72 mmol) and iron powder (4.07 g, 72.82 mmol) were added. The resulting reaction mixture was stirred at a temperature of 80° C. for 2 h and, after cooling to room temperature, concentrated. Ethyl acetate and water were added to the residue and the aqueous phase was then repeatedly extracted with ethyl acetate. The combined organic phases were dried over magnesium sulfate, filtered and concentrated under reduced pressure. Column chromatography purification of the crude product obtained (ethyl acetate/heptane gradient) gave 6-amino-1-propyl-3,4-dihydroquinolin-2(1H)-one (4.0 g, 94percent of theory) as a colorless solid. 1H-NMR (400 MHz, d6-DMSO δ, ppm) 6.79 (d, 1H), 6.45 (m, 1H), 6.42 (m, 1H), 4.85 (br. s, 2H, NH2), 3.75 (m, 2H), 2.68 (m, 2H), 2.43 (m, 2H), 1.52 (m, 2H), 0.85 (t, 3H). Trimethyl phosphite (1 equiv, 8.07 mmol) and 2,4-dimethylbenzyl bromide (1 equiv, 8.07 mmol) were added to a multi-necked flask which had been dried by heating and then stirred together under continuous nitrogen flow at a temperature of 100° C. for 10 h. After complete conversion, without further purification, distilled POCl3 (1 equiv) was added to the resulting crude product and the mixture was stirred under argon at a temperature of 60° C. for 1.5 h. After complete conversion, the methyl (2,4-dimethylbenzyl)phosphonochloridate obtained was, without further purification, directly reacted in the next step. In a round-bottom flask which had been dried by heating, under argon, 6-amino-1-propyl-3,4-dihydroquinolin-2(1H)-one (668 mg, 3.27 mmol) was dissolved in abs. tetrahydrofuran (2 ml) and slowly added dropwise under argon to a solution, cooled to −20° C., of methyl (2,4-methylbenzyl)phosphonochloridate (1065 mg, 3.27 mmol) in abs. tetrahydrofuran (10 ml) in a round-bottom flask which had been dried beforehand by heating. The resulting reaction mixture was stirred at −20° C. for 10 minutes, triethylamine (0.91 ml, 6.54 mmol) was then added and the mixture was subsequently stirred at room temperature for 2 h. The reaction mixture was then filtered, the filter cake was washed with tetrahydrofuran and the filtrate was concentrated under reduced pressure. Column chromatography purification of the crude product obtained (ethyl acetate/heptane gradient) gave methyl N-[1-(n-propylmethyl)-2-oxo-1,2,3,4-tetrahydroquinolin-6-yl]-P-(2,4-dimethylbenzyl)phosphonamidate (57 mg, 4percent of theory) as a colorless solid. 1H-NMR (400 MHz, CDCl3 δ, ppm) 7.00 (m, 1H), 6.95 (m, 1H), 6.88 (m, 1H), 6.85-6.83 (m, 2H), 6.80 (m, 1H), 6.69 (m, 1H), 4.88 (br. s, 1H, NH), 3.86 (m, 2H), 3.76 (d, 3H), 3.32/3.26 (d, 2H), 2.83-2.78 (m, 2H), 2.64-2.59 (m, 2H), 2.26/2.13 (s, 6H), 1.71-1.63 (m, 2H), 0.96 (t, 3H).
69% at 20℃; for 2 h; 3,4-Dihydroquinolin-2(1H)-one (1.54 g, 7.66 mmol) was added to conc. acetic acid (10 mL) and then cautiously admixed with fuming nitric acid (0.42 mL, 10.12 mmol). The resulting reaction mixture was stirred at room temperature for 2 h and then diluted with ice-water. The aqueous phase was then repeatedly extracted with ethyl acetate. The combined organic phases were dried over magnesium sulfate, filtered and concentrated under reduced pressure. By column chromatography purification of the crude product obtained (ethyl acetate/heptane gradient), 6-nitro-3,4-dihydroquinolin-2(1H)-one (1.09 g, 69percent of theory) was isolated as a colorless solid. 6-Nitro-3,4-dihydroquinolin-2(1H)-one (1.30 g, 6.77 mmol) was dissolved under argon in abs. N,N-dimethylformamide (20 mL) and admixed with fine potassium carbonate powder (2.80 g, 20.29 mmol). After stirring at room temperature for 5 min, 2-bromoethyl ethyl ether (1.49 g, 8.79 mmol) and potassium iodide (17 mg, 0.10 mmol) were added. The resulting reaction mixture was stirred at 100° C. for 1.5 h and, after cooling to room temperature, water and ethyl acetate were added. The aqueous phase was then repeatedly extracted with ethyl acetate. The combined organic phases were dried over magnesium sulfate, filtered and concentrated under reduced pressure. By column chromatography purification of the crude product obtained (ethyl acetate/heptane gradient), 1-(ethoxyethyl)-6-nitro-3,4-dihydroquinolin-2(1H)-one (650 mg, 36percent of theory) was isolated as a colorless solid. 1H-NMR (400 MHz, CDCl3 δ, ppm) 8.14 (dd, 1H), 8.05 (d, 1H), 7.45 (d, 1H), 4.14 (t, 2H), 3.70 (t, 2H), 3.50 (q, 2H), 3.01 (m, 2H), 2.72 (m, 2H), 1.16 (t, 3H). In the next step, 1-(ethoxyethyl)-6-nitro-3,4-dihydroquinolin-2(1H)-one (650 mg, 2.46 mmol) was added together with tin(II) chloride dihydrate (2.22 g, 9.38 mmol) to abs. ethanol (10 mL) and the mixture was stirred under argon at a temperature of 40° C. for 5 h. After cooling to room temperature, the reaction mixture was poured onto ice-water and then adjusted to pH 12 with 6 N NaOH. The aqueous phase was then repeatedly extracted with ethyl acetate. The combined organic phases were dried over magnesium sulfate, filtered and concentrated under reduced pressure. By column chromatography purification of the crude product obtained (ethyl acetate/heptane gradient), 6-amino-1-(ethoxyethyl)-3,4-dihydroquinolin-2(1H)-one (620 mg, 97percent of theory) was isolated as a colorless solid. 6-Amino-1-(ethoxyethyl)-3,4-dihydroquinolin-2(1H)-one (150 mg, 0.58 mmol) was dissolved together with (4-chlorophenyl)methanesulfonyl chloride (143 mg, 0.63 mmol) in abs. acetonitrile (7 mL) in a baked-out round-bottom flask under argon, then pyridine (0.09 mL, 1.15 mmol) was added and the mixture was stirred at room temperature for 6 h. The reaction mixture was then concentrated under reduced pressure, the remaining residue was admixed with dil. HCl and dichloromethane, and the aqueous phase was extracted repeatedly with dichloromethane. The combined organic phases were dried over magnesium sulfate, filtered and concentrated under reduced pressure. By column chromatography purification of the crude product obtained (ethyl acetate/heptane gradient), N-[1-(ethoxyethyl)-2-oxo-1,2,3,4-tetrahydroquinolin-6-yl]-1-(4-chloromethylphenyl)methanesulfonamide (139 mg, 62percent of theory) was isolated as a colorless solid. 1H-NMR (400 MHz, CDCl3 δ, ppm) 7.34 (d, 2H), 7.23 (m, 3H), 6.95-6.943 (m, 2H), 6.23 (s, 1H, NH), 4.30 (s, 2H), 4.08 (m, 2H), 3.68 (m, 2H), 3.53 (q, 2H), 2.87 (m, 2H), 2.66 (m, 2H), 1.18 (t, 3H).
60% With sulfuric acid; nitric acid In water at -10 - 0℃; for 0.25 h; To a solution of 3,4-dihydroquinolin-2(lH)-one (1 g) in H2S04 (20 niL) at -10°C, water (5 mL) was added dropwise with stirring. To this solution, concentrated HNO3 (0.5 mL) was added dropwise with stirring, while cooling to a temperature of 0°C. The resulting solution was stirred for 15 min at -10°C. After completion, the mixture was quenched by adding ice water (50 mL). The resulting solution was extracted with EtOAc (5 x 50 mL). The combined organic layers were concentrated under reduced pressure and the resulting crude product was purified by column chromatography over silica gel using EtOAc in hexane as eluent. The product eluted at 50-70percent EtOAc in hexane. The fractions with pure product were concentrated to obtain 6-nitro-3,4-dihydroquinolin- 2(lH)-one as light brown solid (0.9 g, 69percent). 1H NMR (CDC13, 400 MHz): δ 8.549 (brs 1H), 8.116 (brs, 2H), 6.879 (t, 1H), 3.095 (t, 2H), 2.720 (t, 2H).

Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 16, p. 4606 - 4609
[2] Patent: US2007/27184, 2007, A1, . Location in patent: Page/Page column 18; 25
[3] Patent: WO2006/71940, 2006, A2, . Location in patent: Page/Page column 416
[4] Patent: US2008/234237, 2008, A1, . Location in patent: Page/Page column 35
[5] Patent: WO2003/72553, 2003, A1, . Location in patent: Page/Page column 150
[6] Patent: US2004/147760, 2004, A1, . Location in patent: Page 73
[7] Patent: US2018/199575, 2018, A1, . Location in patent: Paragraph 0153-0154
[8] Patent: US2017/27172, 2017, A1, . Location in patent: Paragraph 0187; 0173; 0174; 0181; 0183; 0189
[9] Patent: WO2015/38417, 2015, A1, . Location in patent: Page/Page column 90
[10] Journal of the American Chemical Society, 2014, vol. 136, # 38, p. 13277 - 13282
[11] Proceedings of the Imperial Academy (Tokyo), 1939, vol. 15, p. 148,153[12] Chem. Zentralbl., 1939, vol. 110, # II, p. 3089
[13] Patent: US2003/195201, 2003, A1,
[14] Archiv der Pharmazie, 2008, vol. 341, # 12, p. 794 - 799
[15] Patent: WO2013/159095, 2013, A1, . Location in patent: Paragraph 0082
[16] European Journal of Medicinal Chemistry, 2014, vol. 73, p. 217 - 224
[17] Patent: KR101576386, 2015, B1, . Location in patent: Paragraph 0190-0192
  • 4
  • [ 553-03-7 ]
  • [ 65887-62-9 ]
  • [ 22246-16-8 ]
Reference: [1] Heterocycles, 1998, vol. 48, # 12, p. 2637 - 2641
  • 5
  • [ 62-53-3 ]
  • [ 22246-16-8 ]
Reference: [1] Journal of the American Chemical Society, 2014, vol. 136, # 38, p. 13277 - 13282
[2] Patent: WO2015/38417, 2015, A1,
  • 6
  • [ 3460-04-6 ]
  • [ 22246-16-8 ]
Reference: [1] Journal of the American Chemical Society, 2014, vol. 136, # 38, p. 13277 - 13282
[2] Patent: WO2015/38417, 2015, A1,
  • 7
  • [ 553-03-7 ]
  • [ 7664-93-9 ]
  • [ 7697-37-2 ]
  • [ 22246-16-8 ]
Reference: [1] Proceedings of the Imperial Academy (Tokyo), 1939, vol. 15, p. 148,153[2] Chem. Zentralbl., 1939, vol. 110, # II, p. 3089
  • 8
  • [ 22246-16-8 ]
  • [ 14026-45-0 ]
Reference: [1] Journal of the American Chemical Society, 2014, vol. 136, # 38, p. 13277 - 13282
[2] Patent: WO2013/159095, 2013, A1, . Location in patent: Paragraph 0083
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 22246-16-8 ]

Amides

Chemical Structure| 20870-79-5

[ 20870-79-5 ]

5-Nitroindolin-2-one

Similarity: 0.94

Chemical Structure| 25369-31-7

[ 25369-31-7 ]

7-Nitroindolin-2-one

Similarity: 0.89

Chemical Structure| 4850-93-5

[ 4850-93-5 ]

N-(4-Nitrophenyl)propionamide

Similarity: 0.81

Chemical Structure| 38560-30-4

[ 38560-30-4 ]

1-(4-Nitrophenyl)piperidin-2-one

Similarity: 0.81

Chemical Structure| 611-09-6

[ 611-09-6 ]

5-Nitroindoline-2,3-dione

Similarity: 0.81

Nitroes

Chemical Structure| 20870-79-5

[ 20870-79-5 ]

5-Nitroindolin-2-one

Similarity: 0.94

Chemical Structure| 25369-31-7

[ 25369-31-7 ]

7-Nitroindolin-2-one

Similarity: 0.89

Chemical Structure| 934687-46-4

[ 934687-46-4 ]

4-Isopropyl-6-nitroquinolin-2(1H)-one

Similarity: 0.83

Chemical Structure| 14026-45-0

[ 14026-45-0 ]

6-Nitro-1,2,3,4-tetrahydroquinoline

Similarity: 0.83

Chemical Structure| 4850-93-5

[ 4850-93-5 ]

N-(4-Nitrophenyl)propionamide

Similarity: 0.81

Related Parent Nucleus of
[ 22246-16-8 ]

Tetrahydroquinolines

Chemical Structure| 14026-45-0

[ 14026-45-0 ]

6-Nitro-1,2,3,4-tetrahydroquinoline

Similarity: 0.83

Chemical Structure| 57883-28-0

[ 57883-28-0 ]

1-Ethyl-7-nitro-1,2,3,4-tetrahydroquinoline

Similarity: 0.80

Chemical Structure| 553-03-7

[ 553-03-7 ]

3,4-Dihydroquinolin-2(1H)-one

Similarity: 0.79

Chemical Structure| 22246-13-5

[ 22246-13-5 ]

6-Amino-3,4-dihydroquinolin-2(1H)-one

Similarity: 0.79

Chemical Structure| 40615-17-6

[ 40615-17-6 ]

3-Amino-3,4-dihydroquinolin-2(1H)-one

Similarity: 0.76